{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:40:56Z","timestamp":1768527656569,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.5604\/01.3001.0012.7196","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T06:32:31Z","timestamp":1541399551000},"page":"959-968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and Safety of Ombitasvir\/Paritaprevir\/Ritonavir and Dasabuvir \u00b1 Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Mario G.","family":"Pessoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 V.","family":"Ramalho-Madruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estev\u00e3o P.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Cheinquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Brand\u00e3o-Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Mendes-Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria L.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo R.A.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio R.","family":"\u00c1lvares-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique S.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evaldo S.","family":"Affonso-de-Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juvencio","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymundo","family":"Parana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Lari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tami","family":"Pilot-Matias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy S.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0012.7196_bib0005","doi-asserted-by":"crossref","first-page":"852968","DOI":"10.1155\/2015\/852968","article-title":"Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective","volume":"2015","author":"Castro","year":"2015","journal-title":"Int J Hepatol"},{"key":"10.5604\/01.3001.0012.7196_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-13-60","article-title":"Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study","volume":"13","author":"Pereira","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.5604\/01.3001.0012.7196_bib0015","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s11538-016-0170-4","article-title":"Estimating the Size of the HCV Infection Prevalence: A Modeling Approach Using the Incidence of Cases Reported to an Official Notification System","volume":"78","author":"Amaku","year":"2016","journal-title":"Bull Math Biol"},{"key":"10.5604\/01.3001.0012.7196_bib0020","unstructured":"Brazilian Ministry of Health announces National Plan for Elimination of Hepatitis C by 2030 with the offer of treatment for all. Presentation by Ricardo Barros, Minister of Health. World Hepatitis Summit 2017. Sao Paulo, Brazil, 1-3 November 2017. Available at http:\/\/portalarquivos2.saude.gov.br\/images\/pdf\/2017\/novembro\/01\/Evento-Hepatites-SP-com-edicaoIngles.pdf."},{"key":"10.5604\/01.3001.0012.7196_bib0025","unstructured":"Protocolo cl\u00ednico e diretrizes terap\u00e9uticas para hepatite C e coinfecc\u00f6es. Ministerio da Sa\u00fade, Secretaria de Vigilancia em Saude, Departamento de Vigilancia, Prevencao e Controle das Infeccoes Sexualmente Transmissiveis, do HIV\/ Aids e das Hepatites Virais, Bras\u00edlia. 2017. Available at http:\/\/www.aids.gov.br\/pt-br\/pub\/2017\/protocolo-clinico-e-diretrizes-terapeuticas-para-hepatite-c-e-coinfeccoes Accessed November 14, 2017."},{"key":"10.5604\/01.3001.0012.7196_bib0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7196_bib0035","unstructured":"AASLD-IDSA Guidance Panel. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Available at: https:\/\/www.hcvguidelines.org\/ Accessed November 14, 2017."},{"key":"10.5604\/01.3001.0012.7196_bib0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12072-016-9717-6","article-title":"APASL consensus statements and recommendation on treatment of hepatitis C","volume":"10","author":"Omata","year":"2016","journal-title":"Hepatol Int"},{"key":"10.5604\/01.3001.0012.7196_bib0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL Recommendations on Treatment of Hepatitis C 2016","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7196_bib0050","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJMoa1315722","article-title":"Treatment of HCV with ABT-450\/rombitasvir and dasabuvir with ribavirin","volume":"370","author":"Feld","year":"2014","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0012.7196_bib0055","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMoa1402338","article-title":"ABT-450\/r-ombitasvir and dasabuvir with or without ribavirin for HCV","volume":"370","author":"Ferenci","year":"2014","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0012.7196_bib0060","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJMoa1401561","article-title":"Retreatment of HCV with ABT-450\/r-ombitasvir and dasabuvir with ribavirin","volume":"370","author":"Zeuzem","year":"2014","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0012.7196_bib0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.gastro.2014.04.045","article-title":"ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection","volume":"147","author":"Andreone","year":"2014","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.7196_bib0070","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0012.7196_bib0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jhep.2015.10.005","article-title":"Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir\/paritaprevir\/r and dasabuvir for 12 Weeks","volume":"64","author":"Feld","year":"2016","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7196_bib0080","unstructured":"Copegus (ribavirin) tablets. Prescribing Information. Genentech USA, Inc. South San Francisco, CA, USA."},{"key":"10.5604\/01.3001.0012.7196_bib0085","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2015.07.001","article-title":"Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis","volume":"149","author":"Lawitz","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:40:12Z","timestamp":1761648012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119310580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1665268119310580"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0012.7196","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Ombitasvir\/Paritaprevir\/Ritonavir and Dasabuvir \u00b1 Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0012.7196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}